Key events during the year
- Distribution of the shares in the subsidiary Infant Bacterial Therapeutics (IBT).
- New meta-analysis confirms effectiveness of BioGaia Protectis on colic.
- Meta-analysis confirms effectiveness of BioGaia Prodentis on periodontal disease.
- Agreement for the sale of BioGaia Prodentis in Hong Kong.
- Additional meta-analysis confirms effectiveness of BioGaia Protectis on colic.
- Publication of study showing positive effects of BioGaia Protectis in treatment of abdominal pain in children.
- Publication of study showing that BioGaia Prodentis reduces pregnancy gingivitis.
- Agreement for the sale of drops, tablets and oral rehydration solution in Kenya, Nigeria and Ghana.
- Major new agreements for the sale of BioGaia’s probiotic products in Japan.
- BioGaia makes further investment in MetaboGen.
Key events after the end of 2016
- Agreement for the sale of BioGaia’s products in Thailand.